NCT03926949

Brief Summary

Malnutrition is common in surgical patients. Many studies have shown a clear association between malnutrition and poor surgical outcomes. Parenteral nutrition (PN) is a nutrition intervention that is given by vein and can be safely provided to malnourished patients. It contains carbohydrates, fats, and protein just like you would normally in your diet. Pre-operative PN is able to improve outcomes in surgical patients. However, pre-operative PN has traditionally required hospital admission which results in increased length of stay, hospital cost, and hospital-acquired infection. Moreover, in hospital pre-operative PN may not be feasible or prioritized when access to inpatient surgery beds is limited. Outpatient PN provides the opportunity to solve this problem. The feasibility and impact of outpatient PN in malnourished patients undergoing major surgery have not previously been studied. This study aims to evaluate the feasibility of outpatient pre-operative PN and its effect on patient's outcomes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Oct 2019Jul 2026

First Submitted

Initial submission to the registry

April 15, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 25, 2019

Completed
6 months until next milestone

Study Start

First participant enrolled

October 30, 2019

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

6.8 years

First QC Date

April 15, 2019

Last Update Submit

August 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Rate of parenteral nutrition completion

    Rate of parenteral nutrition completion calculated by the number of patients who can complete parenteral nutrition before surgery for 5-10 days divided by total number of patients in parenteral nutrition group

    through study completion, an average of 1 year

  • Postoperative complications evaluated by Clavien-Dindo Classification

    Clavien-Dindo Classification classifies postoperative complications into 5 grades (grade I to grade V) from mild to severe complications Grade I: no need specific intervention Grade II: need phamacological treatment Grade III: need surgical/endoscopic/radiological intervention Grade IV: life-threatening complications requiring ICU managment Grade V: death of a patient

    through study completion, an average of 1 year

Secondary Outcomes (10)

  • Length of hospital stay

    through study completion, an average of 1 year

  • Quality of life: Short Form (SF)-12 questionnaire

    5-10 days during parenteral nutrition infusion

  • Body weight

    5-10 days during parenteral nutrition infusion

  • Nutrition status

    5-10 days during parenteral nutrition infusion

  • Muscle power

    5-10 days during parenteral nutrition infusion

  • +5 more secondary outcomes

Study Arms (2)

Intervention group

ACTIVE COMPARATOR

Participants will receive parenteral nutrition (Olimel 7.6% E 1000 ml), infused over 4-5 hours at outpatient infusion clinic for 5-10 days within 14 days prior to surgery.

Other: Parenteral Nutrition

Control group

OTHER

Participants will receive nutrition therapy by registered dietitians within 14 days prior to surgery. Patients with SGA B and SGA C will receive advanced nutrition care and specialized nutrition care, respectively

Other: Standard Nutrition Care

Interventions

Olimel 7.6% E 1000 ml will be infused over 4-5 hours at outpatient infusion clinic for 5-10 days within 14 days prior to surgery.

Also known as: Olimel 7.6% E 1000 ml
Intervention group

Participants will receive nutrition therapy by registered dietitians within 14 days prior to surgery. Patients with SGA B and SGA C will receive advanced nutrition care and specialized nutrition care, respectively.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years of age or older
  • Patients screened at risk of malnutrition by Canadian Nutrition Screening Tool (CNST) and identified as malnourished by subjective global assessment (SGA) B or C

You may not qualify if:

  • Patients undergoing minor or laparoscopic surgery
  • Pregnancy
  • Patients with severe systemic diseases defined by American Society of Anesthesiologists (ASA) classification III to V
  • Patients with diabetes mellitus
  • Patients with planned palliative treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Royal Alexandra Hospital

Edmonton, Alberta, T5H 3V9, Canada

RECRUITING

University of Alberta Hospital

Edmonton, Alberta, T6G 2B7, Canada

RECRUITING

MeSH Terms

Conditions

Malnutrition

Interventions

Parenteral Nutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Feeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Leah Gramlich, MD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Narisorn Lakananurak, MD

CONTACT

Leah Gramlich, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2019

First Posted

April 25, 2019

Study Start

October 30, 2019

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

August 21, 2025

Record last verified: 2025-08

Locations